Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

被引:9128
作者
Go, AS
Chertow, GM
Fan, DJ
McCulloch, CE
Hsu, CY
机构
[1] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
关键词
D O I
10.1056/NEJMoa041031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: End-stage renal disease substantially increases the risks of death, cardiovascular disease, and use of specialized health care, but the effects of less severe kidney dysfunction on these outcomes are less well defined. Methods: We estimated the longitudinal glomerular filtration rate (GFR) among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation. We examined the multivariable association between the estimated GFR and the risks of death, cardiovascular events, and hospitalization. Results: The median follow-up was 2.84 years, the mean age was 52 years, and 55 percent of the group were women. After adjustment, the risk of death increased as the GFR decreased below 60 ml per minute per 1.73 m(2) of body-surface area: the adjusted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.1 to 1.2), 1.8 with an estimated GFR of 30 to 44 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.7 to 1.9), 3.2 with an estimated GFR of 15 to 29 ml per minute per 1.73 m(2) (95 percent confidence interval, 3.1 to 3.4), and 5.9 with an estimated GFR of less than 15 ml per minute per 1.73 m(2) (95 percent confidence interval, 5.4 to 6.5). The adjusted hazard ratio for cardiovascular events also increased inversely with the estimated GFR: 1.4 (95 percent confidence interval, 1.4 to 1.5), 2.0 (95 percent confidence interval, 1.9 to 2.1), 2.8 (95 percent confidence interval, 2.6 to 2.9), and 3.4 (95 percent confidence interval, 3.1 to 3.8), respectively. The adjusted risk of hospitalization with a reduced estimated GFR followed a similar pattern. Conclusions: An independent, graded association was observed between a reduced estimated GFR and the risk of death, cardiovascular events, and hospitalization in a large, community-based population. These findings highlight the clinical and public health importance of chronic renal insufficiency.
引用
收藏
页码:1296 / 1305
页数:10
相关论文
共 42 条
  • [11] K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword
    Eknoyan, G
    Levin, NW
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) : S14 - S266
  • [12] The Chronic Renal Insufficiency Cohort (CRIC) study: Design and methods
    Feldman, HI
    Appel, LJ
    Chertow, GM
    Cifelli, D
    Cizman, B
    Daugirdas, J
    Fink, JC
    Franklin-Becker, ED
    Go, AS
    Hamm, LL
    He, JA
    Hostetter, T
    Hsu, CY
    Jamerson, K
    Joffe, M
    Kusek, JW
    Landis, JR
    Lash, JP
    Miller, ER
    Mohler, ER
    Muntner, P
    Ojo, AO
    Rahman, M
    Townsend, RR
    Wright, JT
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07): : S148 - S153
  • [13] Cost of care for patients in cancer clinical trials
    Fireman, BH
    Fehrenbacher, L
    Gruskin, EP
    Ray, GT
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (02) : 136 - 142
  • [14] Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I
    Garg, AX
    Clark, WF
    Haynes, RB
    House, AA
    [J]. KIDNEY INTERNATIONAL, 2002, 61 (04) : 1486 - 1494
  • [15] Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
    Go, AS
    Hylek, EM
    Borowsky, LH
    Phillips, KA
    Selby, JV
    Singer, DE
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (12) : 927 - +
  • [16] Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504
  • [17] Ethnic disparities in diabetic complications in an insured population
    Karter, AJ
    Ferrara, A
    Liu, JY
    Moffet, HH
    Ackerson, LM
    Selby, JV
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19): : 2519 - 2527
  • [18] Karter AJ, 2002, JAMA-J AM MED ASSOC, V288, P46
  • [19] Health care utilization among patients with chronic kidney disease
    Khan, SS
    Kazmi, WH
    Abichandani, R
    Tighiouart, H
    Pereira, BJG
    Kausz, AT
    [J]. KIDNEY INTERNATIONAL, 2002, 62 (01) : 229 - 236
  • [20] Landis JR, 2003, J AM SOC NEPHROL, V14, p294A